All In Biotech

Drug Trial Radar · NCT06798727

Evaluation Safety and Explore Efficacy Long-term Follow-up Study on Subjects Receiving SMUP-IA-01 or Active Control

Last checked: Nov 19, 2026Latest source record: Feb 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

84

Actual

Start

Mar 20, 2023

Primary completion

Mar 20, 2027

Study completion Nov 30, 2027

Sponsor

Lead sponsor
Medipost Co Ltd.Industry
Sponsor type
Industry
First posted
Jan 29, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
Double (participant, care provider)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 19 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a follow-up study to investigate the long-term safety and explore efficacy of SMUP-IA-01, for the treatment of Knee Osteoarthritis. Subjects who participated in and completed the initial stage of the Phase II trial (NCT05182034) will be followed-up until 60 months.

Conditions

  • Knee Osteoarthritis

Interventions

  • SMUP-IA-01(low-dose)Biological

    A single knee administration of SMUP-IA-01(low-dose, 4.0 x 10\^6 cells/2mL)

  • SMUP-IA-01(mid-dose)Biological

    A single knee administration of SMUP-IA-01(mid-dose, 1.0 x 10\^7 cells/2mL)

  • High Hyal PlusDrug

    A single knee administration of Hyaluronic acid(1% Sodium Hyaluronate 20mg/2ml)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change of total score in WOMAC (Western Ontario and McMaster University)Time frame: Time Frame: Month 12, 24, 36, 48 and 60 after treatment

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Seoul Nation University Bundang Hospital

    Gyeonggi-do, South Korea

  • Gangnam Severance Hospital

    Seoul, South Korea

  • Korea University Anam Hospita

    Seoul, South Korea

  • Seoul National University Hospital

    Seoul, South Korea

  • Severance Hospital

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.